Citigroup’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$140K Buy
8,771
+1,691
+24% +$27.1K ﹤0.01% 3520
2025
Q1
$138K Buy
7,080
+15
+0.2% +$291 ﹤0.01% 3638
2024
Q4
$156K Sell
7,065
-1,708
-19% -$37.6K ﹤0.01% 3743
2024
Q3
$148K Sell
8,773
-6,534
-43% -$110K ﹤0.01% 3795
2024
Q2
$183K Buy
15,307
+3,780
+33% +$45.2K ﹤0.01% 3208
2024
Q1
$128K Sell
11,527
-27,794
-71% -$308K ﹤0.01% 3464
2023
Q4
$341K Buy
39,321
+2,699
+7% +$23.4K ﹤0.01% 2928
2023
Q3
$280K Buy
36,622
+1,648
+5% +$12.6K ﹤0.01% 2788
2023
Q2
$252K Sell
34,974
-6,118
-15% -$44.1K ﹤0.01% 3122
2023
Q1
$250K Sell
41,092
-987
-2% -$6.01K ﹤0.01% 2986
2022
Q4
$183K Buy
42,079
+6,094
+17% +$26.6K ﹤0.01% 3086
2022
Q3
$141K Buy
35,985
+23,448
+187% +$91.9K ﹤0.01% 3240
2022
Q2
$64K Sell
12,537
-4,133
-25% -$21.1K ﹤0.01% 3753
2022
Q1
$107K Sell
16,670
-4,657
-22% -$29.9K ﹤0.01% 3694
2021
Q4
$171K Buy
+21,327
New +$171K ﹤0.01% 3681